These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6847954)

  • 1. Influenza vaccines in children. Comparison of new cetrimonium bromide and standard ether-treated vaccines.
    Gross PA; Quinnan GV; Gaerlan PF; Denning CR; Lazicki M; Bernius M
    Am J Dis Child; 1983 Jan; 137(1):26-8. PubMed ID: 6847954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential for single high-dose influenza immunization in unprimed children.
    Gross PA; Quinnan GV; Gaerlan PF; Denning CR; Davis A; Lazicki M; Bernius M
    Pediatrics; 1982 Dec; 70(6):982-6. PubMed ID: 7145555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza immunization in children and young adults: clinical reactions and total and IgM antibody responses after immunization with whole-virus or split-product influenza vaccines.
    Bernstein DI; Zahradnik JM; DeAngelis CJ; Cherry JD
    Am J Dis Child; 1982 Jun; 136(6):513-7. PubMed ID: 7046421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months.
    Bernstein DI; Zahradnik JM; DeAngelis CJ; Cherry JD
    Pediatrics; 1982 Apr; 69(4):404-8. PubMed ID: 7070886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children.
    Englund JA; Walter EB; Fairchok MP; Monto AS; Neuzil KM
    Pediatrics; 2005 Apr; 115(4):1039-47. PubMed ID: 15805382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients.
    Engelhard D; Nagler A; Hardan I; Morag A; Aker M; Baciu H; Strauss N; Parag G; Naparstek E; Ravid Z
    Bone Marrow Transplant; 1993 Jan; 11(1):1-5. PubMed ID: 8431706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and safety of a novel liposomal influenza subunit vaccine (INFLUSOME-VAC) in young adults.
    Ben-Yehuda A; Joseph A; Zeira E; Even-Chen S; Louria-Hayon I; Babai I; Zakay-Rones Z; Greenbaum E; Barenholz Y; Kedar E
    J Med Virol; 2003 Apr; 69(4):560-7. PubMed ID: 12601765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical reactions and antibody responses to influenza vaccines. A comparison of split or subunit vaccines in children and young adults.
    Bernstein DI; Cherry JD
    Am J Dis Child; 1983 Jul; 137(7):622-6. PubMed ID: 6858973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
    Zuccotti GV; Scaramuzza A; Riboni S; Mameli C; Pariani E; Tanzi E; Zanetti A; Radaelli G
    Vaccine; 2009 Aug; 27(39):5357-62. PubMed ID: 19607951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of new triton X-100- and tween-ether-treated split-treated vaccines in children.
    Gross PA; Ennis FA; Gaerlan PF; Denning CR; Setia U; Davis WJ; Bisberg DS
    J Clin Microbiol; 1981 Nov; 14(5):534-8. PubMed ID: 7031085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines.
    Hehme N; Engelmann H; Künzel W; Neumeier E; Sänger R
    Med Microbiol Immunol; 2002 Dec; 191(3-4):203-8. PubMed ID: 12458361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Capacity of anti-influenza subunit vaccines to elicit the formation of heterologous antibodies].
    Profeta ML; Ferrante P
    Boll Ist Sieroter Milan; 1981; 60(4):268-77. PubMed ID: 6895694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy.
    Hanania NA; Sockrider M; Castro M; Holbrook JT; Tonascia J; Wise R; Atmar RL;
    J Allergy Clin Immunol; 2004 Apr; 113(4):717-24. PubMed ID: 15100679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM; Li YQ; Zheng TZ; Jia YP; Li F; Han TW; Qiao RX; Zhang BH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):570-3. PubMed ID: 12975010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Safety and immunogenicity of split vaccines of influenza viruses].
    Zhu CL; Fang HH; Zhu FC; Wang YQ; Wu XL; Xue FB; Shen YJ; Lian JZ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):207-9. PubMed ID: 15640848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serial influenza vaccination with a new subunit vaccine. Tolerance and effectiveness].
    Lutz O; Triebel R; Jahn P; Wiebe K; Schardt F; Kindt H
    Med Welt; 1978 Sep; 29(36):1412-5. PubMed ID: 682923
    [No Abstract]   [Full Text] [Related]  

  • 18. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients.
    Cavdar C; Sayan M; Sifil A; Artuk C; Yilmaz N; Bahar H; Camsari T
    Scand J Urol Nephrol; 2003; 37(1):71-6. PubMed ID: 12745749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial comparing split and subunit influenza vaccines in adults in Colombia.
    Morales A; Arias Salazar J; Salazar Y; García A; Arnoux S; Arancibia A; Deroche C; Rey E
    Medicina (B Aires); 2003; 63(3):197-204. PubMed ID: 12876902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications.
    Baldo V; Baldovin T; Floreani A; Carraro AM; Trivello R;
    Vaccine; 2007 May; 25(20):3955-61. PubMed ID: 17383057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.